Filing Details
- Accession Number:
- 0001140361-15-034400
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-03 17:41:58
- Reporting Period:
- 2015-09-01
- Filing Date:
- 2015-09-03
- Accepted Time:
- 2015-09-03 17:41:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1437402 | Ardelyx Inc. | ARDX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1626854 | S Jeremy Caldwell | C/O Ardelyx, Inc. 34175 Ardenwood Blvd, Suite 200 Fremont CA 94555 | Evp, Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-09-01 | 643 | $18.32 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 12, 2015.
- Consists of 643 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2015.